Sign in

CIK 0001557746

  • Non-accelerated filer
  • Smaller reporting company

Aclaris Therapeutics, Inc.

Sign in to watch
Ticker
ACRS
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
460571712
Phone
+1 484-324-7933
Business address
701 LEE ROAD, SUITE 103, WAYNE, PA, 19087
  1. 4 Shares withheld for taxes President and CEO gave up 47,774 shares (to pay taxes)
  2. 3 Insider Initial Statement of Ownership
  3. 4 Exercise or conversion Director acquired 14,632 shares (option exercise)
  4. 4 Shares withheld for taxes Chief Financial Officer gave up 1,308 shares (to pay taxes)
  5. 4 Shares withheld for taxes Chief Legal Officer gave up 1,318 shares (to pay taxes)
  6. 4 Shares withheld for taxes President and CEO gave up 3,316 shares (to pay taxes)
  7. 4 Shares withheld for taxes President and CEO gave up 871 shares (to pay taxes)
  8. 4 Shares withheld for taxes Chief Financial Officer gave up 370 shares (to pay taxes)
  9. 4 Shares withheld for taxes Chief Legal Officer gave up 498 shares (to pay taxes)
  10. 4 Shares withheld for taxes President and CEO gave up 23,872 shares (to pay taxes)
  11. 4 Shares withheld for taxes Chief Medical Officer gave up 1,360 shares (to pay taxes)
  12. 4 Exercise or conversion Director acquired 7,333 shares (option exercise)
  13. 4 Derivatives Options or other derivatives
  14. 4 Exercise or conversion Director acquired 7,333 shares (option exercise)
  15. 4 Exercise or conversion Director acquired 7,333 shares (option exercise)
  16. 4 Exercise or conversion Director acquired 7,333 shares (option exercise)
  17. 4 Exercise or conversion Director acquired 7,333 shares (option exercise)
  18. 4 Exercise or conversion Director acquired 7,333 shares (option exercise)
  19. 4 Derivatives Options or other derivatives
  20. 4 Shares withheld for taxes President and CEO gave up 20,976 shares (to pay taxes)

Page 11 of 21 · 414 filings